The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C

Piotr Ozieranski; Hoey Amanda; King Lawrence; Roy Victor

The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C

Piotr Ozieranski, Hoey Amanda, King Lawrence, Roy Victor

University of Cambridge

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

Original language	English
Title of host publication	The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C. / Ozieranski, Piotr; Amanda, Hoey; Lawrence, King et al.
The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C. 2015.

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

@inproceedings{eabcebae8f8c42f8b049d3a6037c7fbc,

title = "The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C",

author = "Piotr Ozieranski and Hoey Amanda and King Lawrence and Roy Victor",

year = "2015",

language = "English",

booktitle = "The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C",

}

TY - GEN

T1 - The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C

AU - Ozieranski, Piotr

AU - Amanda, Hoey

AU - Lawrence, King

AU - Victor, Roy

PY - 2015

Y1 - 2015

M3 - Chapter in a published conference proceeding

BT - The politics of breakthrough drug pricing, appraisal and reimbursement in England. A qualitative case study of sofosbuvir for hepatitis C

ER -